Evidence map›Paper›PMID 25405649›Full record

ReviewNeurodegenerative disease management2014

The sleep-wake cycle and Alzheimer's disease: what do we know?

Miranda M Lim, Jason R Gerstner, David M Holtzman

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Neurodegenerative disease management, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03617497 (Prevalence of Epilepsy and Sleep Wake Disorders in Alzheimer Disease), which is not on this map. Cited by 85 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03617497 naunknown statusnot on this mapstarted 2020, after this paper: background citation

Prevalence of Epilepsy and Sleep Wake Disorders in Alzheimer Disease

TypeinterventionalSponsorUniversitaire Ziekenhuizen KU LeuvenRan2020 to 2024Enrolled78ConditionsAlzheimer Disease, Alzheimer Dementia, Epilepsy, Sleep Wake DisordersArmsscalp EEG and polysomnography, scalp EEG with foramen ovale electrodes with polysomnography
3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 1 synthesis or guideline pooled it, 157 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Dorsal raphe tau pathology disrupts sleep-wake orchestration and sleep architecture in a sex-specific manner.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  7. Article
  8. Zolpidem restores sleep and decreases amyloid in a mouse model.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  9. Regulation of autophagy-mediated pathways by diet, physical activity, and sleep in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. 2024 Alzheimer's disease facts and figures.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Miranda M LimDivision of Hospital & Specialty Medicine, Sleep Disorders Laboratory, Portland Veterans Affairs Medical Center, Portland, OR 97239, USA.
Jason R Gerstner
David M Holtzman
Circadian (United States) · USHope Center for Neurological Disorders · USOregon Health & Science University · US

Funding

Smartphone-Based "Burst" Cognitive AssessmentsP01AG003991 · NIA · WASHINGTON UNIVERSITY · PI JOHN MORRIS · 1985 to 2026
$69.5M
Viral Vectors CoreP01NS074969 · NINDS · WASHINGTON UNIVERSITY · PI HOLTZMAN, DAVID M. · 2012 to 2021
$13.0M
TRAINING PROGRAM/RESPIRATORY NEUROBIOLOGY AND SLEEPT32HL007713 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI PACK, ALLAN I · 1992 to 2022
$11.9M
IMAGING COREP01NS080675 · NINDS · WASHINGTON UNIVERSITY · PI RAICHLE, MARCUS E · 2013 to 2017
$6.2M
NHLBI NIH HHS T32 HL007713NIA NIH HHS P01 AG003991NIA NIH HHS P01-AG03991NINDS NIH HHS 1P01NS074969-A1NINDS NIH HHS P01 NS074969NINDS NIH HHS P01 NS080675
6 · The paper itself

Abstract

Sleep-wake disturbances are a highly prevalent and often disabling feature of Alzheimer's disease (AD). A cardinal feature of AD includes the formation of amyloid plaques, associated with the extracellular accumulation of the amyloid-β (Aβ) peptide. Evidence from animal and human studies suggests that Aβ pathology may disrupt the sleep-wake cycle, in that as Aβ accumulates, more sleep-wake fragmentation develops. Furthermore, recent research in animal and human studies suggests that the sleep-wake cycle itself may influence Alzheimer's disease onset and progression. Chronic sleep deprivation increases amyloid plaque deposition, and sleep extension results in fewer plaques in experimental models. In this review geared towards the practicing clinician, we discuss possible mechanisms underlying the reciprocal relationship between the sleep-wake cycle and AD pathology and behavior, and present current approaches to therapy for sleep disorders in AD.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsBrainDisease Models, AnimalDisease ProgressionHumansPlaque, AmyloidSleepSleep Disorders, Circadian RhythmAmyloid beta-PeptidesAlzheimer'samyloidamyloid-βcircadianEEGgliahypocretinorexinsleepwake

Identifiers

PMID25405649
PMCPMC4257134
OpenAlexW1984375619

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.